Survivorship among patients with haematological cancer: Work disability, dementia, and neuropathy
Open Access
- 14 April 2025
- thesis
- Published by Aalborg University
Abstract
No abstract availableKeywords
This publication has 207 references indexed in Scilit:
- Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2023
- Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choiceAmerican Journal of Hematology, 2023
- Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort studyHematological Oncology, 2022
- Income loss after a cancer diagnosis in Germany: An analysis based on the socio‐economic panel surveyCancer Medicine, 2021
- Multiple myeloma: Every year a new standard?Hematological Oncology, 2019
- Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practiceCancer, 2019
- Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic CancersJAMA Oncology, 2018
- Chemotherapy‐induced peripheral neuropathy: A current reviewAnnals of Neurology, 2017
- Associations between cancer and Alzheimer's disease in a U.S. Medicare populationCancer Medicine, 2016
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studiesAnnals of Neurology, 1994